Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness

Academic Emergency Medicine

Volumn 20, Issue 3, 2013, Pages 222-230

  Scheuermeyer, Frank Xavier ^a   Grafstein, Eric ^a   Stenstrom, Rob ^a   Christenson, Jim ^a   Heslop, Claire ^a   Heilbron, Brett ^a   Mcgrath, Lorraine ^a   Innes, Grant ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DILTIAZEM; DRONEDARONE; FLECAINIDE; METOPROLOL; PROPAFENONE; SOTALOL; WARFARIN;

ADVERSE OUTCOME; AGED; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG FATALITY; DRUG SAFETY; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CANADA; COHORT STUDIES; COMORBIDITY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; RETROSPECTIVE STUDIES; STROKE;

EID: 84875312432     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12091     Document Type: Review

References (29)

1. McDonald AJ, Pelletier AJ, Elinor PT, Camargo CA Jr,. Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med. 2008; 51: 58-65.
2. Michael JA, Stiell IG, Agarwal S, Mandavia DP,. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med. 1999; 33: 379-87.
3. Stiell IG, Clement CM, Symington C, Perry JJ, Vaillancourt C, Wells GA,. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. Acad Emerg Med. 2007; 14: 1158-64.
4. Decker WW, Smars PA, Vaidayanathan L, et al. A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation. Ann Emerg Med. 2008; 52: 322-8.
5. Koenig BO, Ross MA, Jackson RE,. An emergency department observation unit protocol for acute-onset atrial fibrillation is feasible. Ann Emerg Med. 2002; 39: 374-80.
6. Mountantonakis SE, Moutzouris DA, Tiu RV,. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation and flutter. Am J Emerg Med. 2006; 24: 407-12.
7. Kafkas NV, Patsilinakos SP, Mertzanos GA, et al. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. Int J Cardiol. 2007; 118: 321-5.
8. Del Arco C, Martin A, Laguna P, Gargantilla P,. Analysis of the current management of atrial fibrillation in the acute setting: GEFAUR-1 study. Ann Emerg Med. 2005; 46: 424-30.
9. Scheuermeyer F, Grafstein E, Stenstrom R, Innes G, Poureslami I, Sighary M,. Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter. Acad Emerg Med. 2010; 17: 408-15.
10. Conti A, Del Tagli B, Mariannini T, et al. Management of patients with acute atrial fibrillation in the ED. Am J Emerg Med. 2010; 28: 903-10.
11. Joseph AP, Ward MR,. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. Ann Emerg Med. 2000; 36: 1-9.
12. Innes GD, Vertesi L, Dillon EC, Metcalfe C,. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation. Ann Emerg Med. 1997; 29: 126-34.
13. Schreck DM, Rivera AR, Tricarico VJ,. Emergency management of atrial fibrillation and flutter: Intravenous diltiazem versus intravenous digoxin. Ann Emerg Med. 1997; 29: 135-40.
14. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation. 2006; 114: E257-354.
15. Fromm C, Suau S, Cohen V, et al. Comparison of diltiazem and metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department: A prospective, randomized double-blind trial [abstract]. Acad Emerg Med. 2011; 18 (Suppl 1): S235.
16. Demircan C, Cikriklar HI, Engindeniz Z, et al. Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation. Emerg Med J. 2005; 22: 411-4.
17. Scheuermeyer F, Grafstein E, Stenstrom R, et al. Thirty-day and one-year outcomes of emergency department patients with atrial fibrillation and no acute underlying medical cause. Ann Emerg Med. 2012; 60: 755-65.
18. Grafstein E, Unger B, Bullard M, Innes G,. for the Canadian Emergency Department Information System (CEDIS) Working Group. Canadian Emergency Department Information System (CEDIS) Presenting Complaint List (Version 1.0). CJEM. 2003; 5: 27-34.
19. Beveridge R, Ducharme J, Janes L, Beaulieu S, Walter S,. Reliability of the Canadian Emergency Department Triage and Acuity Scale: Interrater agreement. Ann Emerg Med. 1999; 31: 155-9.
20. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J,. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med. 1996; 27: 305-8.
21. Worster A, Bledsoe RD, Cleve P, Fernandes CM, Upadhye S, Eva K,. Reassessing the methods of medical record review studies in emergency medicine research. Ann Emerg Med. 2005; 45: 448-51.
22. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ,. Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation. JAMA. 2001; 285: 2864-70.
23. Singer DE, Chang Y, Fang MC, et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009; 151: 297-305.
24. Decker WW, Stead LG,. Selecting rate control for recent-onset atrial fibrillation. Ann Emerg Med. 2011; 57: 32-3.
25. Stead LG, Decker WW,. Rhythm versus rate control for atrial fibrillation and flutter. Ann Emerg Med. 2006; 47: 496-8.
26. Stiell IG, Birnie D,. Clinical controversies: In a vacuum of good evidence, rhythm control is the sensible option for patients with symptomatic recent-onset atrial fibrillation and flutter. Ann Emerg Med. 2011; 57: 31-3.
27. Lee J, Kim K, Lee CC, et al. Low-dose diltiazem in atrial fibrillation with rapid ventricular response. Am J Emerg Med. 2011; 29: 849-54.
28. Than M, Cullen L, Reid CM, et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): A prospective observational validation study. Lancet. 2011; 377: 1077-84.
29. Statistics Canada. Population 5 Years and Over by Mobility Status, by Census Metropolitan Area (2006 Census) (Kelowna, Abbotsford, Vancouver, Victoria). Available at: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/ cst01/demo57 g-eng.htm. Accessed Dec 26, 2012.